Today, following the announcement of the new lower prices negotiated through Medicare – which marked a historic shift in drug pricing policy – P4AD patient advocate Judy Aiken, who takes Enbrel, one of the first 10 negotiated drugs, introduced President Biden and Vice President Harris at an event focused on the new lowered prices.

Today, the Biden-Harris administration released the results of its first-ever drug price negotiations through Medicare, marking a historic shift in drug pricing policy and promising significant savings for nearly nine million American patients.

Federal Judge Deals Another Blow To Pharmaceutical Industry Lawsuits, Upholds Medicare’s Drug Price Negotiation Program

Federal Judge Deals Another Blow To Pharmaceutical Industry Lawsuits, Upholds Medicare’s Drug Price Negotiation Program

Federal Judge Upholds Medicare's Drug Price Negotiation Program, Ruling For Patients And Rejecting Pharmaceutical Industry Lawsuit.

Oral arguments were presented today in the case brought by Boehringer Ingelheim Pharmaceuticals challenging Medicare’s authority to negotiate lower drug prices for patients.

The ongoing legal assault on Medicare negotiation continues as AstraZeneca has filed a notice to appeal a federal judge’s ruling against the company’s lawsuit to overturn the program.

Federal Court Rejects Big Pharma’s "Strongest Arguments" Challenging Constitutionality of Medicare Negotiation Program, Marking Another Win For Patients